Donanemab (Anti-Amyloid Beta)
Product Specifications
CAS Number
1931944-80-7
Synonyms
LY3002813
Target
Beta Amyloid
Applications
Neuronal Signaling
Additionnal Information
Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research. MW : 145.36 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1216700-01 0.02 mg (E-Coli)
Recombinant Clostridium botulinum Sugar fermentation stimulation protein homolog (sfsA)
Sign In for Pricing
View Details MBS1216700-02 0.1 mg (E-Coli)
Recombinant Clostridium botulinum Sugar fermentation stimulation protein homolog (sfsA)
Sign In for Pricing
View Details MBS1216700-03 0.02 mg (Yeast)
Recombinant Clostridium botulinum Sugar fermentation stimulation protein homolog (sfsA)
Sign In for Pricing
View Details MBS1216700-04 0.1 mg (Yeast)
Recombinant Clostridium botulinum Sugar fermentation stimulation protein homolog (sfsA)
Sign In for Pricing
View Details MBS1216700-05 0.02 mg (Baculovirus)
Recombinant Clostridium botulinum Sugar fermentation stimulation protein homolog (sfsA)
Sign In for Pricing
View Details